Evidence map›Paper›PMID 15185861›Full record

ArticleDigestive diseases and sciences2004

In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice.

Elizabeth A Griffiths, Linda C Duffy, Floyd L Schanbacher, Haiping Qiao, Diane Dryja, Allen Leavens, Jon Rossman, Gary Rich, Douglas Dirienzo, Pearay L Ogra

Registry-linked trialAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04642482 (The Effect of Synbiotic on Intestinal Microbiota and HOMA-IR), which is not on this map. Cited by 72 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 3 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04642482 phase4completednot on this mapstarted 2019, after this paper: background citation

The Effect of Synbiotic on Intestinal Microbiota and HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) on Obesity

TypeinterventionalSponsorHasanuddin UniversityRan2019 to 2020Enrolled16ConditionsObesity, Insulin ResistanceArmsSynbiotic (Rillus), Placebo
3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 3 syntheses or guidelines pooled it, 201 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Novel probiotic preparation withMicrobiology spectrum · 2024
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Effect ofPreventive nutrition and food science · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Elizabeth A GriffithsDepartment of Pediatrics, The Women and Children's Hospital of Buffalo, Kaleida Health, School of Medicine, State University of New York at Buffalo, 888 Delaware Avenue, Buffalo, New York 14209, USA.
Linda C Duffy
Floyd L Schanbacher
Haiping Qiao
Diane Dryja
Allen Leavens
Jon Rossman
Gary Rich
Douglas Dirienzo
Pearay L Ogra
Kaleida Health · USWomen & Children's Hospital of Buffalo · USDairy Management · USUniversity at Buffalo, State University of New York · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to examine the effects of oral supplementation of newborn Balb/c mice with bifidobacteria (B. infantis, B. bifidum) and iron-free apo-lactoferrin (bovine, human) on gut endotoxin concentration and mucosal immunity. Endotoxin concentration was measured in ileocecal filtrates at 7, 14, 21, and 28 days postdelivery by a quantitative limulus amebocyte lysate test. While endotoxin levels in bifidobacteria-fed mice showed a steady rise over time, they were consistently lower than that observed in control animals. Results of lactoferrin supplementation varied depending on the specific time point, but overall by day 28, all treatment groups showed lower intestinal endotoxin concentrations compared to saline fed animals. Neither bifidobacteria nor lactoferrin stimulated an increase in B or T cells, or in cytokine production (IL-6, TNF-alpha, INF-gamma), in Peyer's patches as measured by flow cytometry. Bifidobacteria and lactoferrin were well tolerated as dietary supplements and showed promising potential to reduce gut endotoxin levels.

Indexed as

BifidobacteriumAdministration, OralAnalysis of VarianceAnimalsBiomarkersCulture TechniquesEndotoxinsEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryImmunity, MucosalInterferon-gammaInterleukin-6Intestinal MucosaIntestinesLactoferrinBiomarkersEndotoxinsInterferon-gammaInterleukin-6LactoferrinTumor Necrosis Factor-alpha

Identifiers

PMID15185861
OpenAlexW2066901261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.